Beacon attracts $170M series B to push eye disease gene therapy through late-stage trial 0 02.07.2024 12:10 Fiercebiotech.com Beacon attracts $170M series B to push eye disease gene therapy through late-stage trial jwaldron Tue, 07/02/2024 - 05:10
